Application Detail
Status
ClosedDescription of Medical Service
ImmunoHistoChemistry test for evaluation of Programmed Cell Death Ligand 1 (PD-L1) expression to determine eligibility for treatment with pembrolizumabDescription of Medical Condition
Locally advanced or metastatic non-small cell lung cancerReason for Application
New MBS itemMedical Service Type
InvestigativePrevious Application Number
Not ApplicableAssociated Documentation
Application Form
-PICO Confirmation
Final Protocol (PDF 522 KB)Final Protocol (Word 692 KB)
Assessment Report
-Public Summary Document
Public Summary Document (PDF 240 KB)Public Summary Document (Word 98 KB)